Liposarcoma, Myxoid
Showing 26 - 50 of 113
Liposarcoma Trial in United States (efatutazone)
Active, not recruiting
- Liposarcoma
-
Little Rock, Arkansas
- +126 more
Aug 16, 2021
Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)
Recruiting
- Sarcoma, Soft Tissue
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University, Cancer Hospital
Jul 13, 2020
Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)
Withdrawn
- Myxoid Liposarcoma
- +5 more
- Biopsy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2019
Myxoid Liposarcoma Trial in Warsaw (Hypofractionated radiotherapy)
Active, not recruiting
- Myxoid Liposarcoma
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jun 14, 2019
Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma Trial in Seattle (Laboratory Biomarker Analysis, Recombinant
Terminated
- Myxoid Liposarcoma
- +2 more
- Laboratory Biomarker Analysis
- Recombinant Interferon Gamma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 19, 2019
Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of
Recruiting
- Sarcoma,Soft Tissue
- Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
- +2 more
-
Bordeaux, France
- +4 more
Mar 28, 2022
Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60
Active, not recruiting
- Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
- epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
- +5 more
-
Candiolo, TO, Italy
- +14 more
Nov 15, 2021
Sarcoma Trial in Toulouse (Blood samples will be collected at two times :)
Completed
- Sarcoma
- Blood samples will be collected at two times :
-
Toulouse, FranceInstitut Universitaire du Cancer de Toulouse - Oncopole
Dec 9, 2021
Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel (lete-cel, GSK3377794)
- +2 more
-
Duarte, California
- +36 more
Oct 28, 2022
Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)
Recruiting
- Liposarcoma
- Atypical Lipomatous Tumor
- Blood sampling
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022
Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)
Active, not recruiting
- Mesenchymal Chondrosarcoma
-
Prato, Firenze, Italy
- +5 more
Oct 29, 2021
Engagement Patterns and Participation Trends Among Liposarcoma
Not yet recruiting
- Liposarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 8, 2023
Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)
Recruiting
- Liposarcoma, Dedifferentiated
- BI 907828
- Doxorubicin
-
Birmingham, Alabama
- +131 more
Feb 2, 2023
Dedifferentiated Liposarcoma Patients in China
Not yet recruiting
- Dedifferentiated Liposarcoma
-
Beijing, ChinaBeijing Jishuitan hospital
Oct 30, 2023
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Status of Surgical Resection and Histologic Subtype as
Completed
- Liposarcoma of Soft Tissue
- Surgical Procedure, Unspecified
- Retroperitoneal Liposarcoma resection
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da Universidade d
Jun 18, 2022
Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)
Active, not recruiting
- Liposarcoma
- Metastatic Liposarcoma
-
Boston, Massachusetts
- +2 more
Nov 23, 2022
Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)
Completed
- Dedifferentiated Liposarcoma
- Selinexor
- Placebo
-
Los Angeles, California
- +70 more
Jan 5, 2023
Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma
Not yet recruiting
- Advanced Dedifferentiated Liposarcoma
- +5 more
- Palbociclib
- +5 more
- (no location specified)
Jan 11, 2023
Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)
Active, not recruiting
- Ovarian Cancer
- +3 more
-
Duarte, California
- +6 more
Jan 21, 2023
Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )
Not yet recruiting
- Dedifferentiated Liposarcoma
- TQB3616 capsule
- TQB3616 placebo
-
Beijing, Beijing, China
- +2 more
Aug 9, 2022
Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)
Recruiting
- Dedifferentiated Liposarcoma
- +6 more
-
Basking Ridge, New Jersey
- +6 more
May 23, 2023
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)
Recruiting
- Retroperitoneal Sarcoma
- +2 more
- Surgery
- Preoperative chemotherapy
-
Woolloongabba, Queensland, Australia
- +36 more
Dec 27, 2022